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Innate immune signaling relies on the deposition of
non-degradative polyubiquitin at receptor-signaling
complexes, but how these ubiquitin modifications
are regulated by deubiquitinases remains incom-
pletely understood. Met1-linked ubiquitin (Met1-Ub)
is assembled by the linear ubiquitin assembly com-
plex (LUBAC), and this is counteracted by the
Met1-Ub-specific deubiquitinase OTULIN, which
binds to the catalytic LUBAC subunit HOIP. In this
study, we report that HOIP also interacts with the
deubiquitinase CYLD but that CYLD does not regu-
late ubiquitination of LUBAC components. Instead,
CYLD limits extension of Lys63-Ub and Met1-Ub
conjugated to RIPK2 to restrict signaling and cyto-
kine production. Accordingly, Met1-Ub and Lys63-
Ub were individually required for productive NOD2
signaling. Our study thus suggests that LUBAC,
through its associated deubiquitinases, coordinates
the deposition of not only Met1-Ub but also Lys63-
Ub to ensure an appropriate response to innate im-
mune receptor activation.
INTRODUCTION
Ubiquitin (Ub) chains linked via the N-terminal methionine (Met1)
of Ub (Met1-Ub, also termed linear Ub) and lysine 63 (Lys63-Ub)
facilitate innate immune signaling initiated by pattern recognition
receptors (PRRs) such as toll-like receptors (TLRs) and nucle-
otide-oligomerization domain (NOD)-like receptors and cyto-
kine receptors such as tumor necrosis factor (TNF) receptor 1
(TNFR1) (Fiil and Gyrd-Hansen, 2014; Jiang and Chen, 2012).
The linear Ub chain assembly complex (LUBAC), composed of2846 Cell Reports 14, 2846–2858, March 29, 2016 ª2016 The AuthorHOIL-1, HOIP, and SHARPIN, is the only known Ub ligase to
generate Met1-Ub (Gerlach et al., 2011; Ikeda et al., 2011; Kiri-
sako et al., 2006; Tokunaga et al., 2011). LUBAC activity is coun-
terbalanced by the Met1-specific deubiquitinase (DUB) OTULIN
(Fiil et al., 2013; Keusekotten et al., 2013; Rivkin et al., 2013),
which binds to the catalytic subunit HOIP via interactions be-
tween the HOIP peptide:N-glycanase/UBA- or UBX-containing
proteins (PUB) domain and a PUB-interacting motif (PIM) in
OTULIN (Elliott et al., 2014; Schaeffer et al., 2014). The impor-
tance of Met1-Ub in immune signaling is underscored by identi-
fication of mutations within the LUBAC-encoding genes in
human patients with immunological disease (Boisson et al.,
2012, 2015). Lys63-Ub can be generated by Ub ligases that
interact with the dimeric E2 complex Ubc13/Uev1a, which exclu-
sively conjugates this linkage (Deng et al., 2000). Lys63-Ub is
particularly important in MyD88-dependent immune-signaling
pathways activated by TLRs and interleukin-1 receptors (IL-1R)
whereas the role of Lys63-Ub in the NOD-containing protein 2
(NOD2) and TNFR1 pathways is not fully understood (Fiil and
Gyrd-Hansen, 2014; Xu et al., 2009).
NOD2 is an intracellular bacteria-sensing PRR that recognizes
MDP (muramyl dipeptide) constituents of bacterial peptido-
glycan and plays a critical role in gastro-intestinal immunity (Phil-
pott et al., 2014). Upon stimulation, NOD2 binds receptor-inter-
acting protein kinase 2 (RIPK2, also known as RIP2 or RICK),
leading to recruitment of several Ub ligases including the inhibi-
tor of apoptosis (IAP) proteins, cIAP1, cIAP2, and XIAP (Bertrand
et al., 2009; Damgaard et al., 2012). XIAP is indispensable for
NOD2 pathway functionality, where it ubiquitinates RIPK2 to
facilitate recruitment of LUBAC (Bauler et al., 2008; Damgaard
et al., 2012). In turn, LUBAC assembles Met1-Ub on RIPK2 to
enable downstream signal transduction (Fiil et al., 2013). Addi-
tionally, TRAF2, ITCH, cIAP1/2, TRAF6, and PELI3 are reported
to contribute to the assembly of Lys63-Ub on RIPK2, but their in-
dividual contribution to this process and to NOD2 signaling is not
fully resolved (Bertrand et al., 2009; Hasegawa et al., 2008; Taos
et al., 2009; Watanabe et al., 2014; Yang et al., 2013). A central
regulatory point for productive innate immune signaling and tran-
scription of nuclear factor-kB (NF-kB) target genes is the activa-
tion of the IKK (IkB kinase) complex. IKK activation is dependent
on phosphorylation by the TAB/TAK1 complex that interacts with
Lys63-Ub and on the conjugation of Met1-Ub by LUBAC, which
is bound by the IKK subunit NEMO (also known as IKKg; Fiil and
Gyrd-Hansen, 2014; Jiang and Chen, 2012).
For appropriate and beneficial innate immune signaling, the
assembly of Ub chains at receptor complexes must be carefully
counterbalanced byDUBs. The linkage-selective DUBsOTULIN,
CYLD, and A20 regulate various aspects of pro-inflammatory
signaling (Fiil and Gyrd-Hansen, 2014; Harhaj and Dixit, 2012).
The A20 gene (TNFAIP3) is a transcriptional target of NF-kB
and A20 functions as a part of the negative feedbackmechanism
to terminate signaling (Harhaj and Dixit, 2012; Lee et al., 2000).
Contrary to this, OTULIN functions to restrict the accumulation
of Met1-Ub at basal conditions and early during signaling, and
OTULIN expression is not induced by stimulation of NF-kB activ-
ity (Fiil et al., 2013; Keusekotten et al., 2013; Rivkin et al., 2013).
CYLD is a bona fide tumor suppressor and negatively regu-
lates pro-inflammatory signaling (Bignell et al., 2000; Harhaj
and Dixit, 2012). CYLD belongs to the USP (Ub-specific prote-
ase) family of DUBs (Brummelkamp et al., 2003; Kovalenko
et al., 2003; Trompouki et al., 2003) and in vitro cleaves Lys63-
Ub and Met1-Ub with similar efficiency while displaying less
activity toward Lys11-Ub and Lys48-Ub (Komander et al.,
2009; Ritorto et al., 2014; Sato et al., 2015). Unexpectedly,
CYLD was recently reported to interact with HOIP, the catalytic
subunit of LUBAC, and to inhibit LUBAC-dependent activation
of NF-kB (Takiuchi et al., 2014).
Here, we show that, although CYLD is associated with LUBAC
through HOIP binding, CYLD does not regulate ubiquitination of
LUBAC components. Instead, CYLD counteracts Lys63-Ub and
Met1-Ub conjugated to the LUBAC substrate RIPK2 to restrict
signaling and cytokine production. Our results suggest that
LUBAC not only is a Met1-specific E3 but also, through its asso-
ciated DUBs, coordinates Met1- and Lys63-linked Ub chain
assembly at signaling complexes.
RESULTS
CYLD Antagonizes LUBAC Function but Does Not Affect
HOIP Ubiquitination
LUBAC function is restricted by OTULIN through its docking to
the PUB domain of HOIP (Elliott et al., 2014; Schaeffer et al.,
2014). Unexpectedly, CYLD also interacts with LUBAC via the
HOIP PUB domain and mutations, such as N102D, that interfere
with OTULIN binding also interfere with CYLD binding (Takiuchi
et al., 2014; Figures 1A–1C). Moreover, CYLD can, akin to
OTULIN, suppress LUBAC-induced NF-kB activation through
its DUB activity (Takiuchi et al., 2014; Figures 1D and S1A).
This together with the fact that CYLD cleaves Lys63-Ub and
Met1-Ub in vitro (Komander et al., 2009; Sato et al., 2015; Fig-
ure S1B) implies that CYLD and OTULIN might function in a
similar manner to control Met1-Ub conjugation by LUBAC.
To investigate this, we initially tested whether CYLD, like
OTULIN, regulates HOIP ubiquitination. Surprisingly, depletionCellof CYLD in U2OS/NOD2 cells (a cell line expressing doxycycline
[DOX]-inducible HA-NOD2 that responds to the NOD2 ligand
L18-MDP without addition of DOX due to slight leakiness of
the promoter; Fiil et al., 2013) had no effect on HOIP ubiquitina-
tion under basal conditions or after receptor stimulation (Figures
1E and S1C). In contrast, OTULIN depletion led to extensive
accumulation of Met1-Ub on HOIP (Figures 1E and S1C). Affinity
purification of Ub conjugates via linkage-specific Ub binders
(SUBs) selective for Met1-Ub (M1-SUB; Fiil et al., 2013) or
Lys63-Ub (K63-SUB; Sims et al., 2012; Thorslund et al., 2015)
showed that Met1-Ub, but not Lys63-Ub, accumulated on
LUBAC (Figure 1E). Analysis of THP1 human monocytic cells
or HCT-116 human colon carcinoma cells, which both express
NOD2 endogenously, confirmed that CYLD was not involved in
controlling Met1-Ub accumulation on HOIP whereas OTULIN
was indispensable (Figures 1F, 1G, S1D, and S1E). Accordingly,
ectopic expression of inactive OTULIN (C129A), but not inactive
CYLD (C601A), caused extensive accumulation of Met1-Ub on
HOIP (Figures 1H and S1F). This prompted us to explore the
role of CYLD in regulating the NOD2 pathway, which relies on
LUBAC.
CYLD Activity Controls NOD2 Signaling
CYLDhasbeen reported to inhibit RIPK2-induced signalingwhen
overexpressed (Abbott et al., 2004), but the function of endoge-
nous CYLD in NOD2 signaling remains unexplored and its role
as a DUB is unknown. Depletion of CYLD showed that CYLD
limits productive signaling after NOD2 stimulation as determined
by accumulation of transcripts from theNF-kB-responsive genes
TNF andCXCL8 and production of IL-8 (encoded byCXCL8; Fig-
ures 2A and 2B). The requirement for CYLD in restricting NOD2
responses was further validated in CYLD-deficient bone-
marrow-derived dendritic cells (BMDCs), which produced mark-
edly higher levels of pro-inflammatory cytokines than their
wild-type counterparts upon NOD2 activation (Figure 2C).
OTULIN depletion also led to increased IL-8 production, but
the effect was less pronounced as compared to CYLD depletion
(Figures 2D and S2A). Because both DUBs cleave Met1-Ub, we
tested whether depletion of both DUBs would further deregulate
NOD2 signaling. However, we found no additive or synergistic
effect on IL-8 production or on MAP kinase and IKK signaling
when both enzymes were depleted as compared to their individ-
ual depletion (Figures 2D, S2A, and S2B). Interestingly, the
depletion of CYLD did not affect IL-8 production after stimulation
with TNF (Figure 2B), which might reflect a differential depen-
dency of NOD2- and TNFR1-signaling pathways on LUBAC
function (Damgaard et al., 2012; Gerlach et al., 2011). To test
this, the transcriptional response to NOD2 and TNFR1 stimula-
tion was tested in HOIP-deficient HCT-116 (HOIP-KO) cells (Fig-
ure 2E). Transcriptional activation of CXCL8 was ablated in
HOIP-KO cells after NOD2 stimulation but was only reduced af-
ter TNF stimulation (Figure 2F). In fact,CXCL8was inducedmore
than 25-fold in HOIP-KO cells in response to TNF. Also, mea-
surement of NF-kB activity by a luciferase-based reporter
showed that HOIP is required for NOD2-dependent NF-kB acti-
vation whereas TNF-induced NF-kB activation in HOIP KO cells
is only partially decreased (Figure S2C). Reconstitution of the
HOIP-KO cells with ectopic HOIP restored NF-kB activation inReports 14, 2846–2858, March 29, 2016 ª2016 The Authors 2847
Figure 1. CYLD Antagonizes LUBAC Func-
tionbutDoesNotAffectHOIPUbiquitination
(A) Immunoprecipitation of endogenous SHARPIN
from control (MM) and HOIP-depleted U2OS/
NOD2 cells. Lysates and immunoprecipitated
material were examined by immunoblotting.
(B) Immunoprecipitation of exogenous FLAG-
tagged CYLD. Lysates and immunoprecipitated
material were examined for copurification of HOIP.
(C) Immunoprecipitation of exogenous V5-tagged
HOIPWT, HOIPPUB+NZF, and HOIPN102D expressed
in HEK293FT cells. Immunoprecipitated material
was examined for copurification of OTULIN and
CYLD.
(D) NF-kB activity in HEK293FT cell lysates
transfected with dual luciferase reporters, co-ex-
pressed with vector LUBAC (HOIL-1/HOIP),
OTULIN, or CYLD variants as indicated. Luciferase
activity is shown relative to the activity in LUBAC-
transfected cells.
(E) Purification of endogenous Ub conjugates us-
ing UBAUbq, M1-SUB, or K63-SUB in U2OS/NOD2
cell lysates stably depleted for CYLD or OTULIN
and treated with L18-MDP (200 ng/ml; 1 hr) or TNF
(10 ng/ml; 10 min). Purified material and lysates
were examined by immunoblotting.
(F and G) Purification of endogenous Ub conju-
gates in THP1 cells (F) or HCT-116 cells (G) stably
depleted for CYLD or OTULIN and treated with
L18-MDP (200 ng/ml; 1 hr) or TNF (10 ng/ml;
10 min). Purified material and lysates were exam-
ined by immunoblotting.
(H) Purification of endogenous Ub conjugates in
HEK293FT cell lysates transfected with OTULIN or
CYLD variants co-expressed with LUBAC as
indicated. Purified material and lysates were
examined by immunoblotting.
Data in (D) represent the mean ± SEM of at least
three independent experiments, each performed
in duplicate. **p < 0.01. See also Figure S1.response to L18-MDP and TNF, showing that the signaling
defect of the HOIP-KO cells was caused by the absence of
HOIP (Figure S2C).
Next, we investigated the role of the DUB activity of CYLD in
regulating NOD2 signaling. For this, the effect of wild-type
CYLD (CYLDWT) and catalytic inactive CYLD (CYLDC601A) on nu-
clear translocation of the NF-kB subunit RelA and the production
of IL-8 was determined. This showed that the ability of CYLD to
antagonize productive NOD2 signaling relied on its catalytic ac-
tivity (Figures 3A–3C, S3A, and S3B). Also, activation of NF-kB
by ectopic XIAP, an essential Ub ligase for NOD2 signaling,
was blocked by overexpression of CYLDWT, but not CYLDC601A,
which increased NF-kB activity (Figures 3D and S3C). XIAP-
induced NF-kB activity relies not exclusively on Met1-Ub (Dam-
gaard et al., 2012) but was also dependent on Ubc13-mediated
formation of Lys63-Ub (Figures 3E and S3D), which might2848 Cell Reports 14, 2846–2858, March 29, 2016 ª2016 The Authorsexplain why OTULIN only partially in-
hibited XIAP-induced NF-kB activity (Fig-
ure 3D). CYLD and OTULIN were not in-
hibiting NF-kB activity per se becausethe DUBs did not appreciably inhibit NF-kB activity induced by
an engineered non-cleavableMet1-Ub4 protein targeted to inac-
tive XIAP (Fiil et al., 2013; Figures S3E and S3F).
CYLD Limits Extension of Ub Chains on RIPK Proteins
Because CYLD functioned as a DUB to limit NOD2-dependent
signaling but did not regulate LUBAC ubiquitination, we asked
whether depletion of CYLD would affect LUBAC substrate ubiq-
uitination in response to receptor stimulation. Indeed, purifica-
tion of Ub conjugates from control and CYLD-depleted cells
stimulated with L18-MDP revealed that CYLD-depleted cells
accumulated Ub-RIPK2 species containing Lys63 andMet1 link-
ages with a higher apparent molecular weight (MW) than
observed in control cells, particularly at early time points (Figures
4A and S4A). The effect of CYLD depletion on Ub-RIPK2 was
strikingly different from the effect of OTULIN depletion, which
Figure 2. CYLD Restricts NOD2 Signaling and Cytokine Production
(A) Relative levels of TNF and CXCL8 transcripts from U2OS/NOD2 control (siMM) and CYLD-depleted (siCYLD) cells treated with L18-MDP (200 ng/ml; 3 hr)
normalized to untreated siMM.
(B) Intracellular flow cytometry analysis of IL-8 in shRNA control (shMM) U2OS/NOD2 cells or cells stably depleted for OTULIN (shOTLN) or CYLD (shCYLD) in
response to L18-MDP (200 ng/ml; 4 hr) or TNF (10 ng/ml; 4 hr).
(C) WT and Cyld/ BMDCs were stimulated with MDP (10 mg/ml; 24 hr), and secreted cytokines were measured in culture supernatants.
(D) Intracellular flow cytometry analysis of IL-8 in U2OS/NOD2 cells depleted for OTULIN (siOTLN) and CYLD (siCYLD) or control (siMM) using siRNA oligos in
response to L18-MDP (200 ng/ml; 4 hr).
(E) Immunoblot of HOIP levels in control HCT-116 cells and in CRISPR/Cas9 HOIP KO cells.
(F) Relative levels of CXCL8 transcripts from HCT-116 WT and HOIP KO cells treated with L18-MDP (200 ng/ml) and TNF (10 ng/ml) for the indicated times and
normalized to untreated control cells. Data are shown on a two-segmented y axis.
Data in (A), (B), (D), and (F) represent the mean ± SEM of at least three independent experiments, each performed in duplicate. **p < 0.01; n.s. not significant. See
also Figure S2.promoted the accumulation of Ub-RIPK2 species but did not
affect the MW of Ub-RIPK2 as compared with control cells (Fiil
et al., 2013; Figure 4B).
CYLD is reported to be a transcriptional target of NF-kB in
response to TNF and IL-1b treatment and to contribute to termi-
nation of signaling (Jono et al., 2004). However, depletion of
CYLD did not stabilize RIPK2 ubiquitination at late time points af-
ter NOD2 stimulation (Figure 4A). Also, NOD2 stimulation did not
increase CYLD (or OTULIN) mRNA or protein levels whereas
TNFAIP3 (A20) mRNA and protein levels rapidly increased by
the treatment (Figures 4C and 4D). This suggested that CYLD
regulates ubiquitination at the initiation of signaling. In line withCellthis, TNF treatment of CYLD-depleted cells led to accumulation
of Ub-RIPK1 species with a higher apparent MW than observed
in non-depleted cells within 10 min (Figure 4E), which coincided
with the recruitment of CYLD to the TNFR-SC (Figure 4F). CYLD
also co-purified with HA-NOD2 induced by DOX in U2OS/NOD2
cells, and under these conditions, CYLD levels were unaffected
by the treatment (Figure 4G).
The ubiquitination of RIPK2 and RIPK1 after NOD2 and TNFR1
stimulation, respectively, is facilitated by several E3 Ub ligases,
including XIAP and cIAPs. The continuous assembly of Ub
chains within receptor-signaling complexes might therefore
mask the regulation of ubiquitination by DUBs. To better assessReports 14, 2846–2858, March 29, 2016 ª2016 The Authors 2849
Figure 3. CYLD Catalytic Activity Inhibits the NOD2 Pathway Upstream of Nuclear Translocation of NF-kB
(A) Immunofluorescence analysis of nuclear translocation of the NF-kB subunit RelA/p65 (red) in response to L18-MDP (1 mg/ml; 1 hr) in U2OS/NOD2 cells
transfected with FLAG-CYLD variants and stained with anti-FLAG (green; scale bar, 10 mm).
(B) Quantification of cells with nuclear RelA treated as in (A).
(C) Intracellular flow cytometry analysis of IL-8 in U2OS/NOD2 cells transfected with FLAG-CYLD variants in response to L18-MDP (200 ng/ml; 4 hr). Cells were
cotransfected with a GFP vector (ratio 1:10) as a marker of transfection.
(D) NF-kB activity in HEK293FT cell lysates transfected with dual luciferase reporters, XIAP, CYLD, and OTULIN as indicated. Values are expressed relative to
XIAP transfection.
(E) NF-kB activity in HEK293T cell lysates transfected with luciferase reporters, vector, or XIAP and depleted for Ubc13 using two different siRNAs. Values are
expressed relative to XIAP transfection.
Data in (B)–(E) represent the mean ± SEM of at least three independent experiments, each performed in duplicate. **p < 0.01; *p < 0.05. See also Figure S3.the regulation of Ub chains by CYLD, we therefore treated cells
with a Smac-mimetic compound (compound A [CpA]) to inhibit
IAP function prior to receptor stimulation. When used at high
concentrations (1 mM), CpA blocks RIPK2 ubiquitination in
response to L18-MDP (Figures 5A, lanes 1–4, and S5A) because
the compound antagonizes the interaction of XIAP with RIPK2 in
addition to inducing degradation of cIAPs (Damgaard et al.,
2013). Remarkably, depletion of CYLD under these conditions
restored RIPK2 ubiquitination to comparable levels as in
NOD2-stimulated cells not treated with CpA (Figure 5A, compare
lane 8 with lanes 3 and 7). Depletion of OTULIN also led to accu-
mulation of Ub-RIPK2 albeit to a lesser extent than when CYLD
was depleted (Figure 5A, compare lane 12 with lanes 3 and 11).
CpA also impaired the ubiquitination of RIPK1 in response to2850 Cell Reports 14, 2846–2858, March 29, 2016 ª2016 The AuthorTNF, and depletion of CYLD partially restored RIPK1 ubiquitina-
tion (Figures 5B, compare lanes 4 and 8, and S5B). This suggests
that CYLD and OTULIN, especially at the NOD2 receptor com-
plex, are highly active in regulating Ub chain stability.
CpA prevented the degradation of IkBa by L18-MDP in non-
depleted cells but in CYLD-depleted cells IkBa levels were
reduced after stimulation, suggesting that CYLD depletion
restored productive signaling (Figure 5A, compare lanes 4
and 8). However, CpA inhibited IL-8 production in CYLD-
depleted cells to a similar extent as in in control or OTULIN-
depleted cells (Figure 5C). In contrast, CpA had no effect on
IL-8 induced by phorbol myristate acetate (PMA) and ionomycin,
indicating that the compound was not interfering with IL-8 pro-
duction non-specifically (Figure 5D).s
Figure 4. CYLD Limits Extension of Ub Chains on RIPK Proteins
(A) Purification of Ub conjugates from U2OS/NOD2 cells at indicated time points after treatment with L18-MDP (200 ng/ml). Purified material was examined for
ubiquitinated RIPK2 by immunoblotting.
(B) Purification of Ub conjugates from control or OTULIN- or CYLD-depleted U2OS/NOD2 cells treated with L18-MDP (200 ng/ml; 1 hr). Purified material and
lysate were examined by immunoblotting.
(C and D) Relative mRNA (C) and protein (D) levels of CYLD,OTULIN, and TNFAIP3 (A20) upon L18-MDP stimulation (200 ng/ml) of U2OS/NOD2 cells at the time
points indicated. Asterisk denotes unspecific band detected by the antibody.
(E) Purification of Ub conjugates from U2OS/NOD2 cells treated with TNF (10 ng/ml; 10 min). Purified material and lysate were examined for RIPK1 by immu-
noblotting.
(F) Purification of TNFR-SC from U2OS/NOD2 cells stimulated with FLAG-TNF using anti-FLAG agarose and analyzed by immunoblotting.
(G) Immunoprecipitation of HA-NOD2 from U2OS/NOD2 cells. HA-NOD2 expression was induced with DOX (2 mg/ml) for 24 hr. Immunoprecipitates were
examined for co-purification of CYLD and other members of the NOD2 receptor complex.
Data in (C) represent the mean ± SEM of at least three independent experiments, each performed in duplicate. **p < 0.01. See also Figure S4.
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Figure 5. Inhibition of IAPs Reveals Extensive Regulation of RIPK2 Ubiquitination by CYLD and OTULIN
(A and B) Purification of endogenous Ub conjugates from U2OS/NOD2 cells depleted for CYLD or OTULIN by siRNA. Cells were pre-treated with DMSO (control)
or with 1 mM compound A (CpA) for 30 min before stimulation with (A) L18-MDP (200 ng/ml; 1 hr) or (B) TNF (10 ng/ml; 10 min).
(C and D) Intracellular flow cytometry analysis of IL-8 in control (MM) U2OS/NOD2 cells or cells depleted for CYLD or OTULIN by siRNA pre-treatedwith 1 mMCpA
for 30min before stimulation with (C) L18-MDP (200 ng/ml; 4 hr) or (D) combination of phorbol myristate acetate (PMA) (50 ng/ml) and ionomycin (500 mM) for 4 hr.
Data in (C) and (D) represent the mean ± SEM of at least three independent experiments, each performed in duplicate. **p < 0.01.
See also Figure S5.CYLD Trims Lys63- and Met1-Ub on RIPK2
To address which Ub-linkage(s) CYLD regulates in the context of
NOD2 pathway activation, we subjected Ub conjugates isolated
with glutathione S-transferase (GST)-M1-SUB (Figure 6A) or
GST-UBAUbq (Figure 6B) to Ub chains restriction (UbiCRest)
analysis (Hospenthal et al., 2015). Incubation with OTULINWT,
but not inactive OTULINC129A, resulted in a gel shift of Ub-
RIPK2, but the digested Ub-RIPK2 from CYLD-depleted cells
still migrated significantly slower than Ub-RIPK2 from control
cells (Figures 6A, compare lanes 1 and 3 with lanes 7 and 9,
and 6B, compare lanes 2 and 5 with lanes 9 and 12). Additional
Met1 linkages could thus not alone account for the slower
migrating Ub-RIPK2 species in CYLD-depleted cells. Incubation
with the Lys63-selective DUBs OTUD1 or AMSH* (Michel et al.,
2015) also resulted in a similar gel shift of Ub-RIPK2 isolated
from control and CYLD-depleted cells (Figure 6B, compare lanes
2, 3, and 6 with lanes 9, 10, and 13). However, incubation with2852 Cell Reports 14, 2846–2858, March 29, 2016 ª2016 The AuthorOTULIN plus OTUD1 or OTULIN plus AMSH* resulted in similar
migration patterns of Ub-RIPK2 isolated from control and
CYLD-depleted cells, indicating that CYLD restricts the deposi-
tion of both Lys63 and Met1 linkages on RIPK2 (Figure 6B,
compare lanes 4 and 7 with lanes 11 and 14). The extent of Ub
chain digestion and linkage specificity in the DUB reactions
was determined by linkage-specific antibodies and by spiking
into the reaction recombinant Met1-linked Ub4 with an N-termi-
nal GSTmoiety. This indicated that OTUD1 and OTULIN cleaved
the intended linkage largely to completion without detectable
cross-reactivity with Met1- or Lys63-Ub, respectively (Figures
S6A and S6B). Curiously, a substantial fraction of the high-MW
signal detected by the Met1-Ub antibody disappeared in the
OTUD1-treated samples even though OTUD1 did not digest
GST-Met1-Ub4. This could reflect that Met1 linkages in gen-
eral are conjugated to existing Lys63-Ub although the remain-
ing signal in the OTULIN-treated samples suggests that thes
Figure 6. CYLD Trims Lys63- and Met1-Ub on RIPK2
(A) UbiCRest analysis of ubiquitinated RIPK2 isolated with M1-SUB from L18-MDP-treated (200 ng/ml; 1 hr) control (siMM) or CYLD-depleted (siCYLD) U2OS/
NOD2 cells. Purified Ub conjugates were incubated with the indicated DUBs for 1 hr, and samples were examined by immunoblotting.
(B) As in (A) except ubiquitinated RIPK2 was isolated with GST-UBAUbq followed by incubation with the indicated DUBs for 15 min and cells were stably depleted
for CYLD (shCYLD) or control (shMM). Black dashed line separates two scans of the same membrane but with slightly different exposure.
(C) As in (B) except that Ub conjugates were purified from THP-1 cells and incubated for 1 hr.
See also Figure S6.Met1-Ub antibody also can react with Ub chains other than
Met1-Ub (Figure S6A).
Notably, incubation of the purified Ub conjugates with AMSH*
or OTUD1, but not with OTULIN, generated significant amounts
of monoUb-RIPK2 and oligoUb-RIPK2, suggesting that Lys63
linkages are generated proximal to RIPK2 whereas Met1 link-
ages are only conjugated to polyubiquitinated RIPK2 (Figures
6B, 6C, and S6A–S6C). The viral DUB vOTU disassembles all
Ub linkages except Met1 (Hospenthal et al., 2015) and served
as a positive control alongwith USP21 in the UbiCREST analysis,
where they removed virtually all Ubmoieties from RIPK2 (Figures
6A and 6C).
Lys63-Ub and Met1-Ub Are Individually Indispensable
for NOD2 Signaling
Lys63-Ub had been suggested to contribute to NOD2 signaling,
and our investigation of CYLD’s function supported this notion.CellHowever, the direct evidence for the requirement of the Lys63
linkage was still lacking. To address this, we expressed GFP-
coupled variants of the K63-SUB and M1-SUB (Figure 7A) in
order to interfere with the function of Lys63-Ub and Met1-Ub,
respectively, as was previously reported (Fiil et al., 2013; Sims
et al., 2012). Indeed, expression of GFP-K63-SUB inhibited the
nuclear localization of RelA and production of IL-8 after NOD2
stimulation to a similar extent as GFP-M1-SUB despite being ex-
pressed at lower levels (Figures 7B–7D, S7A, and S7B). Gating of
cells based on GFP expression revealed that low levels of GFP-
K63-SUB were sufficient to block IL-8 production whereas GFP-
M1-SUB inhibited IL-8 production only when highly expressed
(Figure 7E). As expected, GFP-negative cells (not successfully
transfected) responded similarly to NOD2 stimulation in all con-
ditions (Figures 7C and 7E).
A substantial fraction of GFP-K63-SUB appeared to localize to
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between cytoplasm and nucleus (Figure 7B). We therefore
generated variants with a nuclear localization signal (NLS) and
transfected cells with nuclear-localized variants. This showed
that the GFP-SUBs exclusively inhibited signaling in the cyto-
plasm because neither NLS-GFP-K63-SUB nor NLS-GFP-M1-
SUB inhibited IL-8 production (Figures 7F and S7A).
Consistent with an important function of Lys63-Ub for NOD2
signaling, depletion of Ubc13 inhibited IL-8 production to a
similar extent as the depletion of HOIP (Figure 7G). Similar ef-
fects were obtained in cells where either CYLD or OTULIN was
stably silenced, albeit the inhibitory effect of Ubc13 or HOIP
depletion on IL-8 production was slightly less effective and
depletion of both proteins was needed to completely prevent
IL-8 production (Figure 7G). Altogether, our data reveal that the
NOD2 pathway is exquisitely dependent on Lys63-Ub and
Met1-Ub and suggest that the regulation of these linkages is co-
ordinated by LUBAC through its associated DUBs CYLD and
OTULIN.
DISCUSSION
In this study, we revealed that CYLD restricts deposition of
Lys63-Ub and Met1-Ub on the LUBAC substrate RIPK2 to limit
NOD2-dependent inflammatory signaling. We showed that
CYLD, like OTULIN, interacts with LUBAC, suggesting that the
Ub-regulating capacity of LUBAC complexes extends beyond
Met1-Ub to also include Lys63-Ub.
There are several examples of Ub ligase-DUB pairs where a
DUB either regulates substrate ubiquitination or auto-ubiquitina-
tion of the Ub ligase, notably the Mdm2-USP7 complex that reg-
ulates p53 stability and the DUB A20, which also harbors Ub
ligase activity (Tang et al., 2006; Wertz et al., 2004). However,
we are not aware of other examples than LUBAC-OTULIN-
CYLD, where anUb ligase associates with two separate DUB ac-
tivities. It is possible that LUBAC exists as different complexes
containing either CYLD or OTULIN because they both require
residues within the PIM-binding pocket (e.g., N102) for interac-
tion with HOIP. However, the LUBAC complex elutes as an
600-kDa complex and may thus contain two or more HOIP
molecules, allowing for binding of both DUBs within the same
complex (Kirisako et al., 2006). Supporting the latter scenario,
HOIP oligomerizes via the N-terminal part of the protein (Elliott
et al., 2014), and CYLD has been shown to co-immunoprecipi-
tate OTULIN in a LUBAC-dependent manner and vice versa
(Takiuchi et al., 2014). Moreover, we found that the removal of
Met1-Ub conjugated to HOIP was independent of CYLD but
was entirely dependent on OTULIN’s catalytic activity and its
binding to LUBAC (Elliott et al., 2014), arguing for the existence
of a ternary LUBAC-CYLD-OTULIN complex.
The molecular basis preventing CYLD from processing Met1-
Ub on HOIP is not clear, but it could be via inaccessibility of
CYLD, but not OTULIN, to the chains. OTULIN has high affinity
for Met1 chains, several fold higher than reported for NEMO,
the prototypical Met1-Ub-binding protein (Keusekotten et al.,
2013; Rahighi et al., 2009). Possibly, HOIL-1 or another factor
with Met1-Ub-binding capacity (Haas et al., 2009) would prevent
CYLD from gaining access to and cleaving the Met1-Ub on
HOIP, whereas OTULIN would have access via its higher affinity2854 Cell Reports 14, 2846–2858, March 29, 2016 ª2016 The Authortoward Met1-Ub. However, further investigations are needed to
uncover the basis of this differential role of CYLD and OTULIN in
regulation of HOIP ubiquitination. It will also be of interest to
investigate the possibility that HOIP ubiquitination could be an
auto-regulatory mechanism controlled by OTULIN, for example,
by inhibiting intrinsic LUBAC activity or affecting its recruitment
to receptor complexes.
CYLD Regulation of LUBAC Substrates
An important insight from our study was that CYLD regulates the
extension of Lys63 andMet1 linkages on RIPK2. Although deple-
tion of CYLD resulted in extended Ub modifications on RIPK2
(and RIPK1 after TNF treatment), the full extent of regulation of
RIPK2 ubiquitination by CYLD (and OTULIN) was uncovered
only when we functionally inhibited IAP proteins. CYLD also
regulated the ubiquitination of RIPK1, but inhibition of IAP pro-
teins had a less dramatic effect. This suggests that deposition
of Ub modifications at the NOD2 complex, the TNFR1 complex,
and possibly other immune complexes is continuously coordi-
nated through the opposing activities of Ub ligases and DUBs.
This could enable dynamic alterations to the linkage composition
of Ub chains within these signaling complexes. Such a mecha-
nism is described for A20, which removes Lys63 linkages and
assembles Lys48-Ub to terminate signaling (Wertz et al., 2004).
In response to IL-1R stimulation, Met1 linkages are formed
almost exclusively on existing Lys63-Ub conjugated to IRAK1,
a component of the MyD88 signalosome (Emmerich et al.,
2013). Analogously, the Ub-linkage composition of Ub-RIPK2
following NOD2 stimulation showed that Lys63-Ub is the first
linkage type conjugated to RIPK2 whereas Met1 linkages are
formed only on RIPK2 molecules that are already polyubiquiti-
nated (Fiil et al., 2013). An intriguing possibility is that CYLD
functions to trim Lys63-linked Ub chains to facilitate their Met1
ubiquitination by LUBAC.
Of note, during revision of this manuscript, a study by Draber
et al. (2015) reported that OTULINwas not stably associated with
receptor-signaling complexes and suggested that OTULIN does
not regulate ubiquitination of RIPK2. However, the data pre-
sented here and in our previous study (Fiil et al., 2013) indicate
that OTULIN has access to the endogenous NOD2 complex
(irrespective of whether it associates stably or not), where it re-
stricts RIPK2 ubiquitination alongside CYLD. The underlying
reason for the discrepancy is not clear at this time but could
be due to a difference in experimental approaches.
Functional Role of CYLD and Lys63-Ub
The functional requirement of Lys63-Ub for immune receptor
signaling is controversial and appears to be specific to individual
receptor systems (Ori et al., 2013; van Wijk et al., 2012; Xu et al.,
2009). It was therefore important to establish whether or not
K63-Ub contributes to NOD2 signaling. Using linkage-selective
Ub binders to interfere with Lys63-Ub function together with
silencing of the E2 Ubc13, we established that Lys63 linkages
are essential for productive NOD2 signaling. Interestingly, the
NOD2 pathway is equally dependent on LUBAC function and
Met1-Ub (Damgaard et al., 2012; Warner et al., 2013), illustrating
the non-redundant signaling properties of these linkages. In
contrast, Lys63-Ub is reported to be largely dispensable in thes
Figure 7. Lys63-Ub and Met1-Ub Are Individually Indispensable for NOD2 Signaling
(A) Schematic representation of the GFP-tagged Ub-binding constructs used for transient expression in cells (GFP-M1-SUB: UBAN domain from NEMO; GFP-
K63-SUB: three UIMs from RAP80 in tandem).
(B) Immunofluorescence analysis of nuclear translocation of RelA (red) in response to L18-MDP stimulation (1 mg/ml; 1 hr) or no treatment (NT) in U2OS/NOD2
cells transfected with GFP, GFP-K63-SUB, or GFP-M1-SUB (green) for 24 hr. The scale bar represents 10 mm.
(C) Quantification of (B).
(D) Intracellular flow cytometry analysis of IL-8 in U2OS/NOD2 cells transfected as indicated for 48 hr before L18-MDP stimulation (200 ng/ml; 4 hr).
(legend continued on next page)
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TNFR1 pathway (van Wijk et al., 2012; Xu et al., 2009), and
although Met1-Ub contributes to pro-inflammatory signaling, it
also has a prominent role in regulating the formation of cell death
complexes (Gerlach et al., 2011; Ikeda et al., 2011; Keusekotten
et al., 2013). The molecular basis underlying the receptor-spe-
cific functions of Lys63- and Met1-Ub is not understood, but it
might reflect how ubiquitination is coordinated at receptor com-
plexes. For example, the generation of Lys63/Met1 hybrid chains
in the IL-1R pathway probably explains the exquisite depen-
dency on the Lys63 linkage within the system (Emmerich et al.,
2013).
Even though CYLD is well known to regulate inflammation
and innate immune responses, its role in regulating the NOD2
pathway had not been defined. In line with the requirement of
Lys63- and Met1-Ub in NOD2, but not TNFR1, signaling, we
found that endogenous CYLD was critical for limiting productive
NOD2 signaling but that it did not appreciably affect TNF
signaling as judged by IL-8 production. Interestingly, CYLD is
reported to negatively regulate the innate immune response to
infection by Listeria monocytogenes, an intracellular bacterial
pathogen recognized by NOD1 and NOD2 (Kim et al., 2008;
Nishanth et al., 2013). This suggests that the regulation of
RIPK2 ubiquitination by CYLD (and LUBAC and OTULIN) could
influence the response to infection by intracellular bacteria.
In conclusion, our study exemplifies how ubiquitination
following innate immune receptor activation is carefully controlled
by LUBAC and its associated DUB activities CYLD and OTULIN
for accurate regulation of downstream signaling and pro-inflam-
matory responses.
EXPERIMENTAL PROCEDURES
Purification of Endogenous Ub Conjugates
Ub conjugates were purified from cell lysates using affinity reagents TUBE,
M1-SUB, and K63-SUB (Fiil et al., 2013; Thorslund et al., 2015) or UBAUbq.
Briefly, cells were lysed in buffer containing 20 mM Na2HPO4, 20 mM
NaH2PO4, 1% (v/v) NP-40, and 2 mM EDTA and supplemented with 5 mM
N-ethylmaleimide, cOmplete protease inhibitors, and PhosSTOP (Roche).
The affinity reagents TUBE (50 mg/ml), M1-SUB (100 mg/ml), K63-SUB
(15 mg/ml), or UBAUbq (150 mg/ml) were either added directly to the cell lysates
or pre-bound to Glutathione Sepharose 4B beads (GE Healthcare) for at least
1 hr. For K63-SUB pull-down, the Thermo Scientific Pierce Streptavidin Mag-
netic Beads were washed in lysis buffer and incubated with the biotinylated
K63-SUB in the lysis buffer for at least 1 hr agitating at 4C, followed by three
washes. For all pull-downs, lysates were cleared by centrifugation, mixed with
beads, and incubated agitating at 4C for a minimum of 2 hr. The beads were
washed four times in 500 ml of ice-cold PBS 0.1% (v/v) Tween-20 or TUBE
lysis buffer. The bound material was eluted with 15 mM glutathione in PBS
or with 13 sample loading buffer.
Immunofluorescence Staining and Confocal Microscopy
Low-density U2OS/NOD2 cell cultures grown on coverslips were transfected
using Fugene6 (Promega) according to manufacturer’s protocol. After 24 hr,
the cells were stimulated with 1 mg/ml L18-MDP for 1 hr. The cells were fixed(E) Gating of cells in (D) based on GFP levels (relative fluorescence units [RFUs]).
value defining the lower limit, except of the ‘‘zero’’ RFU population, which includ
(F) As in (D) except that GFP, GFP-K63-SUB, or GFP-M1-SUB contains a nuclea
(G) Intracellular flow cytometry analysis of IL-8 in control (MM) U2OS/NOD2 cells o
by siRNA as indicated; and treated with L18-MDP (200 ng/ml; 4 hr) or not treate
Data in (C)–(G) represent the mean ± SEM of at least three independent experim
2856 Cell Reports 14, 2846–2858, March 29, 2016 ª2016 The Authorin 4% formaldehyde and permeabilized by 0.1% (v/v) Triton X-100 in PBS.
Blocking was performed in 5% (w/v) BSA and 0.01% (v/v) Triton X-100 in
PBS, and cells were stained with primary antibodies and fluorescently labeled
secondary antibodies in the blocking solution for 1 hr at room temperature.
The nuclei were stained with 1 mg/ml DAPI for 10 min. Coverslips were
mounted on slides using ProLong Gold Antifade Reagent (Life Technologies).
Images were acquired on a Carl Zeiss LSM710 confocal microscope equip-
ped with 203 dry and 633 oil lenses. To quantify RelA translocation, images
were semi-automatically processed in FiJi software using a macro. Briefly, nu-
clear staining (DAPI channel) was used to create a mask, which was used to
measure fluorescence intensities in green (transfected cells) and red (RelA)
channels.
Intracellular Flow Cytometry of IL-8
U2OS/NOD2 cells, transfected using Fugene6, were stimulated 24–48 hr after
transfection with 200–300 ng/ml L18-MDP for 4–6 hr in the presence of 5 mg/ml
Brefeldin A and 2 mMMonensin (BioLegend) protein transport inhibitors. After
stimulation, cells were washed with PBS, dissociated by Trypsin/EDTA solu-
tion (GIBCO Life Technologies), and collected by centrifugation. Cells were
fixed with IC Fixation Buffer (eBioscence) O/N at 4C; washed with PBS; per-
meabilized using Perm/Wash Buffer containing 2% (v/v) FCS, 0.1% (w/v)
saponin, and 0.1% (w/v) NaN3 in PBS; and incubated in the Perm/Wash Buffer
with anti-IL-8/allophycocyanin (APC) for 1 hr at room temperature. The cells
were analyzed by FACS Canto Flow Cytometer (BD Bioscience) and data pro-
cessed using FlowJo software (TreeStar). APC and GFP levels were acquired
using 633 nm and 488 nm laser, respectively.
DUB Assays
Ub conjugates from L18-MDP-treated cells were isolated by M1-SUB
(100 mg/ml) or GST-UBAUbq (150 mg/ml) pre-bound to GST beads as described
under purification of endogenous Ub conjugates. After wash, beads were re-
suspended in DUB buffer (50 mM HEPES [pH 7.5], 100 mM NaCl, 2 mM
DTT, 1 mM MnCl2, and 0.01% Brij-35). For siMM/shMM or siCYLD/shCYLD
U2OS/NOD2 experiments, Ub conjugates incubated without or with DUBs
(USP21 [0.5 mM], OTULIN [0.4–1 mM], OTULIN C/A [1 mM], vOTU [0.4 mM],
OTUB1 [15 mM], OTUD1 [0.2 mM], and AMSH* [3 mM]). Samples were incubated
for 15min (Figure 6B) or 1 hr (Figure 6A). For the time course experiment, DUBs
OTUD1 (0.2 mM) andOTULIN (0.4 mM) incubatedwith the Ub conjugates for 15,
60, or 240 min and USP21 (0.5 mM) and the no DUB control incubated for
60 min. For spiked in GST-Met1-Ub4 experiments, 4 mg was added to the
Ub conjugates and incubated with DUBs (OTULIN [0.4 mM] and OTUD1
[0.2 mM]) or no DUB for 4 hr. For the THP1 cells, Ub conjugates incubated
for 1 hr with or without DUBs OTULIN (1 mM), OTUD1 (1 mM), and Usp21
(0.5 mM). All samples incubated at 30C with shaking, and loading sample
buffer was added to stop the reaction.
Cytometric Bead Array
Secreted cytokines (Il-1b, IL-6, and TNF) weremeasured from culture superna-
tants from BMDC after 24 hr with or without MDP with the Cytometric Bead
Array (CBA) (BD Biosciences) according to manufacturer’s protocol.
Generation of Stable CRISPR/Cas9 HCT-116 Cells
To generate stable HCT-116 knockout cell lines, the cells were transfected us-
ing Fugene HD with the RNF31 CRISPR/Cas9 KO Plasmid (sc-412436; Santa
Cruz Biotechnology) containing gRNA, Cas9, and EGFP marker. After 36 hr,
top 10% of GFP-positive cells were sorted by flow cytometry and cloned by
limiting dilution to obtain single-cell clones. Individual clones were validated
by western blotting with HOIP-specific antibodies.RFU values on x axis indicate the maximal RFU in each gate with the previous
es cells with values up to 100 RFUs.
r localization signal (NLS).
r cells stably depleted for CYLD or OTULIN; depleted for HOIP, Ubc13, or both
d (NT).
ents, each performed in duplicate. **p < 0.01. See also Figure S7.
s
Statistical Analysis
Statistical analysis was performed in Using Prism 6 (GraphPad Software). The
two-tailed Student’s tests were used to determine statistical significance in
Figures 1D, 3D, and 3E; at all other instances, two-way ANOVA was used to
determine statistical significance.
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